- Home
- DTF vs BMGL Comparison
DTF vs BMGL Comparison
Compare DTF & BMGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTF
- BMGL
- Stock Information
- Founded
- DTF 1991
- BMGL 2001
- Country
- DTF United States
- BMGL Singapore
- Employees
- DTF N/A
- BMGL N/A
- Industry
- DTF Investment Managers
- BMGL
- Sector
- DTF Finance
- BMGL
- Exchange
- DTF Nasdaq
- BMGL NYSE
- Market Cap
- DTF 78.2M
- BMGL 78.3M
- IPO Year
- DTF N/A
- BMGL 2025
- Fundamental
- Price
- DTF $11.24
- BMGL $1.66
- Analyst Decision
- DTF
- BMGL
- Analyst Count
- DTF 0
- BMGL 0
- Target Price
- DTF N/A
- BMGL N/A
- AVG Volume (30 Days)
- DTF 21.1K
- BMGL 2.4M
- Earning Date
- DTF 01-01-0001
- BMGL 01-01-0001
- Dividend Yield
- DTF 3.64%
- BMGL N/A
- EPS Growth
- DTF N/A
- BMGL N/A
- EPS
- DTF 0.44
- BMGL 0.02
- Revenue
- DTF N/A
- BMGL $7,342,469.00
- Revenue This Year
- DTF N/A
- BMGL N/A
- Revenue Next Year
- DTF N/A
- BMGL N/A
- P/E Ratio
- DTF $24.34
- BMGL $91.98
- Revenue Growth
- DTF N/A
- BMGL 2.28
- 52 Week Low
- DTF $10.29
- BMGL $0.91
- 52 Week High
- DTF $11.19
- BMGL $9.40
- Technical
- Relative Strength Index (RSI)
- DTF 53.80
- BMGL N/A
- Support Level
- DTF $11.16
- BMGL N/A
- Resistance Level
- DTF $11.23
- BMGL N/A
- Average True Range (ATR)
- DTF 0.04
- BMGL 0.00
- MACD
- DTF 0.00
- BMGL 0.00
- Stochastic Oscillator
- DTF 64.29
- BMGL 0.00
About DTF DTF Tax-Free Income 2028 Term Fund Inc.
DTF Tax-Free Income 2028 Term Fund Inc is a diversified closed-end management investment company. The Fund's investment objective is current income exempt from regular federal income tax consistent with the preservation of capital. It seeks to achieve its investment objective by investing primarily in a diversified portfolio of investment-grade tax-exempt obligations.
About BMGL BASEL MEDICAL GROUP LTD
Basel Medical Group Ltd provides general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. Key revenue is generated from Singapore.